CN103768537A - Traditional Chinese medicine composition for treating qi-stagnation and blood stasis type angina pectoris - Google Patents
Traditional Chinese medicine composition for treating qi-stagnation and blood stasis type angina pectoris Download PDFInfo
- Publication number
- CN103768537A CN103768537A CN201410059638.2A CN201410059638A CN103768537A CN 103768537 A CN103768537 A CN 103768537A CN 201410059638 A CN201410059638 A CN 201410059638A CN 103768537 A CN103768537 A CN 103768537A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- rhizoma
- fructus
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese medicine composition for treating qi-stagnation and blood stasis type angina pectoris. The traditional Chinese medicine composition comprises the following components in parts by mass: salvia miltiorrhiza, radix astragali, rhizoma corydalis, radix ophiopogonis, ligusticum wallichii, radix curcumae, pericarpium citri reticulatae viride, caulis spatholobi, fructus crataegi, fructus trichosanthis, ginseng, peach kernel, saffron crocus, red paeony root, rhizoma cyperi, fructus aurantii, dried orange peel, liquorice, angelica sinensis, radix bupleuri, lignum dalbergiae odoriferae, fructus amomi, rhizoma acori graminei, trogopterus dung, radix polygonati officinalis, pseudo-ginseng, jasmine flower, sandalwood and borneol. The cure rate of the traditional Chinese medicine composition for qi-stagnation and blood stasis type angina pectoris is 92%.
Description
Technical field
The present invention relates to one and treat anginal medicine, relate in particular to the anginal Chinese medicine composition for the treatment of qi stagnation and blood stasis type.
Background technology
Coronary heart disease, according to the difference of clinical manifestation, can be divided into angina pectoris, myocardial infarction, heart failure and arrhythmia.Same patient may have one or more clinical symptoms, need to classify and treat.Can find out from prior art, obtain on this problem unification, but curative effect also needs to improve.The Syndrome Differentiation of Traditional Chinese Medicine complexity of coronary heart disease, clinical can, according to situations such as the real deficiency in origin of mark, simulataneous insufficiency and excessive, being divided into polytype and being treated.Particularly, comprise stagnation of QI due to depression of the liver, conscience disorder type, qi stagnation and blood stasis type, the turbid impatency type of expectorant, stagnant type in the expectorant stasis of blood, stasis blocking heart network type, type of obstruction of heart-blood, etc.Prior art often adopts same prescription to treat all types of coronary heart disease, dialectical inaccurate, and its curative effect is to be worth discussion.
Prior art discloses the prescription of some treatment patient qi depressions to blood stasis, and it can be used as the reference for the treatment of qi stagnation and blood stasis type angina pectoris.
98111918.2(1061890C) relate to a kind of Chinese powder medicine for the treatment of qi depression to blood stasis, it comprises Rhizoma Typhonii, Rhizoma Arisaematis sheet, Olibanum, Myrrha, Rhizoma Et Radix Notopterygii, Radix Angelicae Sinensis, Resina Draconis, the Radix Angelicae Dahuricae, Rhizoma Gastrodiae, Radix Saposhnikoviae, Flos Carthami and Rhizomadioscoreae.This powder can effectively improve disturbance of blood circulation, especially effective to cerebral thrombosis.
201110327233.9 relate to a kind of Chinese medicine for the treatment of amenorrhea of stagnancy qi and blood stasis type, Radix Bupleuri 10-15g, Radix Paeoniae Alba 10-15g, Rhizoma Cyperi 9-12g, Rhizoma Chuanxiong 10-15g, Flos Carthami 10-15g, Radix Angelicae Sinensis 10-15g, Herba Leonuri 10-15g, eupolyphaga 9-12g.
201210039673.9 relate to one treats the prostatitic Chinese medicine of qi stagnation and blood stasis type, and it comprises Folium Artemisiae Argyi 10-25, Radix Salviae Miltiorrhizae 10-20, Radix Kansui 1-5, Flos Carthami 10-20, Olibanum 15-25, Myrrha 10-20, Rhizoma Dioscoreae Bulbiferae 10-20, Rhizoma Acori Graminei 10-20.
200610112704.3(1907327B) a kind of pharmaceutical composition for the treatment of cardiovascular and cerebrovascular diseases caused by qi stagnation blood stasis is disclosed, it comprises Radix Salviae Miltiorrhizae and Radix Notoginseng.This case is by optimizing the ratio of Radix Salviae Miltiorrhizae and Radix Notoginseng total arasaponins, to improve the object of curative effect.
Except above-mentioned patent documentation, the medicines such as Xindakang preparation, tablet for coronary heart disease and hypertension and Shuxin Oral can be treated angina pectoris to a certain extent, but cure rate and curative effect all have much room for improvement.
Summary of the invention
For solving the problem of prior art, the invention provides one and treat the anginal Chinese medicine composition of qi stagnation and blood stasis type.This Chinese medicine composition is according to the feature of qi stagnation and blood stasis type angina pectoris, the important component such as reasonable compatibility Radix Ginseng and Oletum Trogopterori, and reaching has no side effect treats angina pectoris.
One is treated the anginal Chinese medicine composition of qi stagnation and blood stasis type, it is characterized in that, according to the mass fraction, consist of the following composition: 200 ~ 210 parts of Radix Salviae Miltiorrhizaes, 200 ~ 210 parts of the Radixs Astragali, 135 ~ 145 parts of Rhizoma Corydalis, 135 ~ 145 parts of Radix Ophiopogonis, 135 ~ 145 parts of Rhizoma Chuanxiongs, 135 ~ 140 parts of Radix Curcumaes, 125 ~ 130 parts, Pericarpium Citri Reticulatae Viride, 120 ~ 129 parts of Caulis Spatholobis, 120 ~ 129 parts of Fructus Crataegis, 120 ~ 129 parts of Fructus Trichosanthis, 120 ~ 125 parts of Radix Ginsengs, 105 ~ 110 parts, Semen Persicae, 105 ~ 110 parts of Stigma Crocis, 105 ~ 110 parts of Radix Paeoniae Rubra, 90 ~ 110 parts of Rhizoma Cyperis, 90 ~ 110 parts of Fructus Aurantiis, 86 ~ 110 parts of Pericarpium Citri Reticulataes, 86 ~ 89 parts, Radix Glycyrrhizae, 86 ~ 89 parts of Radix Angelicae Sinensis, 86 ~ 89 parts of Radix Bupleuri, 80 ~ 90 parts of Lignum Dalbergiae Odoriferaes, 80 ~ 90 parts of Fructus Amomis, 80 ~ 85 parts of Rhizoma Acori Graminei, 74 ~ 76 parts of Oletum Trogopteroris, 55 ~ 60 parts of Rhizoma Polygonati Odorati, 55 ~ 60 parts of Radix Notoginseng, 15 ~ 25 parts of Flos Jasmini Sambacs, 15 ~ 25 parts, Lignum Santali Albi, 8 ~ 10 parts of Borneolum Syntheticums.
As preferably: 205 parts of Radix Salviae Miltiorrhizaes, 205 parts of the Radixs Astragali, 140 parts of Rhizoma Corydalis, 140 parts of Radix Ophiopogonis, 140 parts of Rhizoma Chuanxiongs, 135 parts of Radix Curcumaes, 125 parts, Pericarpium Citri Reticulatae Viride, 125 parts of Caulis Spatholobis, 125 parts of Fructus Crataegis, 125 parts of Fructus Trichosanthis, 124 parts of Radix Ginsengs, 108 parts, Semen Persicae, 108 parts of Stigma Crocis, 108 parts of Radix Paeoniae Rubra, 100 parts of Rhizoma Cyperis, 100 parts of Fructus Aurantiis, 95 parts of Pericarpium Citri Reticulataes, 88 parts, Radix Glycyrrhizae, 88 parts of Radix Angelicae Sinensis, 88 parts of Radix Bupleuri, 90 parts of Lignum Dalbergiae Odoriferaes, 90 parts of Fructus Amomis, 85 parts of Rhizoma Acori Graminei, 75 parts of Oletum Trogopteroris, 55 parts of Rhizoma Polygonati Odorati, 55 parts of Radix Notoginseng, 25 parts of Flos Jasmini Sambacs, 20 parts, Lignum Santali Albi, 9 parts of Borneolum Syntheticums.
As preferably: 205 parts of Radix Salviae Miltiorrhizaes, 210 parts of the Radixs Astragali, 135 parts of Rhizoma Corydalis, 145 parts of Radix Ophiopogonis, 135 parts of Rhizoma Chuanxiongs, 135 parts of Radix Curcumaes, 130 parts, Pericarpium Citri Reticulatae Viride, 120 parts of Caulis Spatholobis, 120 parts of Fructus Crataegis, 129 parts of Fructus Trichosanthis, 125 parts of Radix Ginsengs, 105 parts, Semen Persicae, 105 parts of Stigma Crocis, 105 parts of Radix Paeoniae Rubra, 90 parts of Rhizoma Cyperis, 110 parts of Fructus Aurantiis, 86 parts of Pericarpium Citri Reticulataes, 89 parts, Radix Glycyrrhizae, 86 parts of Radix Angelicae Sinensis, 86 parts of Radix Bupleuri, 110 parts of Lignum Dalbergiae Odoriferaes, 80 parts of Fructus Amomis, 80 parts of Rhizoma Acori Graminei, 76 parts of Oletum Trogopteroris, 60 parts of Rhizoma Polygonati Odorati, 55 parts of Radix Notoginseng, 20 parts of Flos Jasmini Sambacs, 15 parts, Lignum Santali Albi, 8 parts of Borneolum Syntheticums.
As preferably: 210 parts of Radix Salviae Miltiorrhizaes, 200 parts of the Radixs Astragali, 145 parts of Rhizoma Corydalis, 145 parts of Radix Ophiopogonis, 135 parts of Rhizoma Chuanxiongs, 140 parts of Radix Curcumaes, 126 parts, Pericarpium Citri Reticulatae Viride, 129 parts of Caulis Spatholobis, 120 parts of Fructus Crataegis, 120 parts of Fructus Trichosanthis, 122 parts of Radix Ginsengs, 105 parts, Semen Persicae, 105 parts of Stigma Crocis, 110 parts of Radix Paeoniae Rubra, 90 parts of Rhizoma Cyperis, 110 parts of Fructus Aurantiis, 100 parts of Pericarpium Citri Reticulataes, 89 parts, Radix Glycyrrhizae, 89 parts of Radix Angelicae Sinensis, 86 parts of Radix Bupleuri, 85 parts of Lignum Dalbergiae Odoriferaes, 85 parts of Fructus Amomis, 82 parts of Rhizoma Acori Graminei, 74.6 parts of Oletum Trogopteroris, 60 parts of Rhizoma Polygonati Odorati, 55 parts of Radix Notoginseng, 25 parts of Flos Jasmini Sambacs, 25 parts, Lignum Santali Albi, 8 parts of Borneolum Syntheticums.
As preferably: 200 parts of Radix Salviae Miltiorrhizaes, 205 parts of the Radixs Astragali, 145 parts of Rhizoma Corydalis, 145 parts of Radix Ophiopogonis, 145 parts of Rhizoma Chuanxiongs, 137 parts of Radix Curcumaes, 128 parts, Pericarpium Citri Reticulatae Viride, 120 parts of Caulis Spatholobis, 129 parts of Fructus Crataegis, 125 parts of Fructus Trichosanthis, 120 parts of Radix Ginsengs, 110 parts, Semen Persicae, 105 parts of Stigma Crocis, 105 parts of Radix Paeoniae Rubra, 90 parts of Rhizoma Cyperis, 90 parts of Fructus Aurantiis, 86 parts of Pericarpium Citri Reticulataes, 89 parts, Radix Glycyrrhizae, 89 parts of Radix Angelicae Sinensis, 86 parts of Radix Bupleuri, 110 parts of Lignum Dalbergiae Odoriferaes, 110 parts of Fructus Amomis, 84 parts of Rhizoma Acori Graminei, 74 parts of Oletum Trogopteroris, 58 parts of Rhizoma Polygonati Odorati, 58 parts of Radix Notoginseng, 15 parts of Flos Jasmini Sambacs, 22 parts, Lignum Santali Albi, 10 parts of Borneolum Syntheticums.
One is used for the treatment of the anginal Chinese medicinal capsule of qi stagnation and blood stasis type, it is characterized in that, comprises described Chinese medicine composition.
One is used for the treatment of the anginal Chinese medicinal pill of qi stagnation and blood stasis type, it is characterized in that, comprises described Chinese medicine composition and Mel, and mass ratio is 1:0.5 ~ 1.5.
One is used for the treatment of the anginal Chinese medicine preparation of qi stagnation and blood stasis type, it is characterized in that comprising described Chinese medicine composition and solvent.
In this Chinese medicine preparation, described solvent is rice wine, and by mass percentage, the proportioning of itself and Chinese medicine composition is 1:8 ~ 10.
In this Chinese medicine preparation, described solvent is yellow wine, and by mass percentage, the proportioning of itself and Chinese medicine composition is 1:5 ~ 10.
In this Chinese medicine preparation, described solvent is ethanol, and by mass percentage, the proportioning of itself and Chinese medicine composition is 1:1 ~ 6.
The anginal Chinese medicine composition of this treatment qi stagnation and blood stasis type of the present invention, has the effect such as blood circulation promoting and blood stasis dispelling, promoting the circulation of QI to relieve pain, cures mainly qi stagnation and blood stasis type angina pectoris, and cure rate is about 92%.This Chinese medicine composition is considering, on the basis of each constituent content, to have optimized the proportioning of Radix Ginseng and Oletum Trogopterori, the effect that has improved blood circulation promoting and blood stasis dispelling.Although this Chinese medicine composition is formed by several kinds of Chinese medicinal materials compatibility, it cures mainly clearly, has no side effect.Meanwhile, diabetes and the metabolic arthritis that can bring out coronary heart disease can be alleviated or cure to this Chinese medicine composition.
The specific embodiment
Treat anginal scheme for the present invention being more clearly described, first summarizing prior art some that provide.Background technology part has explained, no longer describes in detail.Patent, patent application and other documents that the application directly quotes, include this case in as a reference, and the part that other do not do to express, with reference to known technology.
Existing patent documentation discloses multiple documents that are used for the treatment of coronary heart disease.
201110048251.3(102119971B) relate to a kind of Chinese medicine for the treatment of coronary heart disease, it comprises Ramulus Persicae 1-3 part, Herba Potentillae Discoloris 1-3 part, Moschus 0.5-1 part, Pemisetum flaccidum Griseb. 2-5 part, Herba Plantaginis 1-3 part and anistree 0.5-1 part.Coronary heart disease differentiation of symptoms and signs for classification of syndrome complexity, same component is difficult for all types of coronary heart disease for the treatment of.
Treat coronary heart disease 201310342311.1 relate to one, anginal medicine, Flos Carthami 20-60g, the white 20-60g of a round bamboo basket, Radix Platycodonis 10-30g, Rhizoma Acori Graminei 5-15g, Ramulus Cinnamomi 10-30g, Rhizoma Corydalis 10-20g, Fructus Trichosanthis 30-100g, Herba Potentillae Discoloris 10-30g, Moschus 10-30g, Radix Aucklandiae 10-30g, Semen Platycladi 20-60g, Caulis Spatholobi 10-30g, Radix Ophiopogonis 10-30g, Herba Plantaginis 20-60g, Radix Puerariae 10-30g, Rhizoma Curculiginis 10-20g, Oletum Trogopterori 10-30g, Semen Persicae 10-20g, Radix Polygalae 20-60g, Semen Lepidii (Semen Descurainiae) 10-30g, big gun first 5-15g, Fructus Toosendan 5-15g, Rhizoma Zingiberis 5-15g, Radix Glycyrrhizae Preparata 10-30g.
201210541518.7 relate to a kind of Chinese medicine composition for angina pectoris, are prepared from by the traditional Chinese medicinal composition raw materials of following weight proportion: Rhizoma Corydalis 220-260 part, Moschus 4-12 part, Styrax 4-12 part, Rhizoma Chuanxiong 100-140 part, Radix Ginseng 100-140 part, Borneolum Syntheticum 6-18 part.Borneolum Syntheticum GUIXIN, liver, can control blood stasis.Borneolum Syntheticum is poisonous, should limit its intake.
201110453345.9 disclose a kind of Chinese medicine composition for the treatment of angina pectoris, and it is by Radix Codonopsis, the Radix Astragali, Fructus Mori, Rhizoma Chuanxiong, Radix Curcumae, Oletum Trogopterori, Flos Rosae Rugosae, Semen Litchi and Lignum Aquilariae Resinatum.Radix Codonopsis, the Radix Astragali, Fructus Mori, Rhizoma Chuanxiong, Radix Curcumae, Oletum Trogopterori are the good medicine for the treatment of qi stagnation and blood stasis type coronary heart disease.
201110174824.7 relate to a kind of medicine for the treatment of coronary heart disease, it has optimized the proportioning of American ginseng total saponins and tetrahydropalmatine.
201110155727.3 relate to the Chinese medicine for the treatment of coronary heart disease, and it comprises 25～50 parts, Radix Rehmanniae Preparata, 10～25 parts of Fructus Corni, 15～30 parts of Herba Cistanches, 5～20 parts of gun additioners, 5～15 parts of Radix Ginsengs, 15～25 parts of Radix Ophiopogonis, 2.5～10 parts of Fructus Schisandrae Chinensis, 5～15 parts of Ramulus Cinnamomi, 5～10 parts, Radix Glycyrrhizae, 10～25 parts of Radix Angelicae Sinensis, 15～50 parts of the Radixs Astragali, 15～50 parts of Radix Salviae Miltiorrhizaes, 1.5～5 parts, Lignum Santali Albi, 5～10 parts of Fructus Amomis, 5～15 parts of Rhizoma Chuanxiongs, 10～20 parts of Fructus Crataegis, 15～25 parts of Flos Lonicerae, 15～25 parts of Radix Scrophulariaes, 15～50 parts, the Radix Rehmanniae.This case is treated all types of coronary heart disease with same component.
Although ancient Chinese medicine has the saying of " Radix Ginseng fear Oletum Trogopterori ", modern TCM research shows, in rational proportioning or reasonably under solvent action, people participates in Oletum Trogopterori compatibility can treat various diseases.For example, " Radix Ginseng, the experimentation of Oletum Trogopterori compatibility to the effect of A549 human lung adenocarcinoma cell line " (Traditional Chinese Medicinal College of Liaoning. Wang Jin), the chemical substance basic research of Oletum Trogopterori " Radix Ginseng fear " (time precious traditional Chinese medical science traditional Chinese medicines. ring D etc. makes a whistling sound), " Radix Ginseng join Oletum Trogopterori " mutual restraint between two drugs " simple analysis " Liu Yuchun etc., and " the modern study progress of Radix Ginseng, Oletum Trogopterori compatibility " (Chinese Chinese medicine magazine. Li Lian Jun etc.) all this is done careful research.Certainly, the proportion compatibility that people participates in Oletum Trogopterori has to consider the impact of other compositions in prescription, such as Radix Salviae Miltiorrhizae, the Radix Astragali etc.Existing patent documentation also discloses the patent scheme of some ginseng compatibility's Oletum Trogopteroris.Consider other components in prescription, in this application, Radix Ginseng: Oletum Trogopterori is 120 ~ 125:74 ~ 76.
01131203.3(1124153B) disclose a kind of medicinal composition for restoring cardiac collaterals, be used for the treatment of angina pectoris.It Radix Ginseng, Radix Codonopsis, Radix Pseudostellariae, the Radix Astragali, the Rhizoma Atractylodis Macrocephalae, Radix Glycyrrhizae, Rhizoma Dioscoreae that comprises Rational Dosage clinically wherein one or more, Hirudo, Radix Salviae Miltiorrhizae, Rhizoma Chuanxiong, Flos Carthami, Radix Paeoniae Rubra, Lignum Dalbergiae Odoriferae, Radix Notoginseng, Radix Curcumae, Semen Persicae, Rhizoma Corydalis, Eupolyphaga Seu Steleophaga, Olibanum, Sanguis Draxonis, Myrrha, Caulis Spatholobi, Lignum Aquilariae Resinatum, Rhizoma Curcumae, Rhizoma Sparganii, Herba Leonuri, Oletum Trogopterori, Radix Achyranthis Bidentatae, Fructus Trichosanthis, the Rhizoma Pinelliae, Bulbus Allii Macrostemonis, Semen Armeniacae Amarum, Fructus Aurantii, Fructus Aurantii Immaturus, Lignum Santali Albi, Rhizoma Cyperi, the Radix Aucklandiae, Pericarpium Citri Reticulatae, Radix Platycodonis, Rhizoma Corydalis, Radix Polygoni Multiflori, Radix Angelicae Sinensis, Radix Rehmanniae Preparata, the Radix Paeoniae Alba, Radix Ophiopogonis, Rhizoma Polygonati, Borneolum Syntheticum, Rhizoma Acori Graminei, Semen Ziziphi Spinosae, Radix Polygalae, succinum, Herba Asari, Radix Aconiti Lateralis Preparata, Ramulus Cinnamomi, Herba Epimedii, Fructus Schisandrae Chinensis, Fructus Crataegi, Radix Puerariae, Poria, the Radix Angelicae Dahuricae, Radix Bupleuri, Pheretima, wherein one or more and Scorpio of Rhizoma Gastrodiae, Periostracum Cicadae, Scolopendra is the combination preparation of one or more wherein.The specific embodiments of this case is more, and each component all has the effect of blood circulation promoting and blood stasis dispelling, but whether all can be used for treating angina pectoris, needs empirical research.
200810127216.9 relate to a kind of medicated wine for the treatment of coronary heart disease, and it comprises Radix Salviae Miltiorrhizae, Rhizoma Corydalis, Fructus Crataegi, Radix Ginseng, Cortex Cinnamomi, Radix Angelicae Sinensis, Cordyceps, Flos Carthami, Rhizoma Chuanxiong, Vascular aurantii, Herba Saussureae Involueratae, Radix Notoginseng, Oletum Trogopterori and sticky rice wine.In this case, people participates in Oletum Trogopterori equivalent.
200810127966.6 disclose a kind of method for the treatment of swine coronary diseases with traditional Chinese medicines, Radix Salviae Miltiorrhizae, Rhizoma Corydalis, Fructus Crataegi, Radix Ginseng, Cortex Cinnamomi, Radix Angelicae Sinensis, Cordyceps, Flos Carthami, Rhizoma Chuanxiong, Vascular aurantii, Herba Saussureae Involueratae, Radix Notoginseng, Oletum Trogopterori.In this case, Radix Ginseng is less than Oletum Trogopterori.It is said, this component can be used for the treatment of swine coronary diseases.
200910234765.0 relate to a kind of Chinese medicine for the treatment of swine coronary diseases, are made up of 20 grams of 40 grams of Semen Cassiaes, 50 grams of Radix Salviae Miltiorrhizaes, 20 grams of the Rhizoma Anemarrhenaes, 30 grams of Fructus Crataegis, 10 grams of Radix Ginsengs, 20 grams of Radix Paeoniae Rubra, 20 grams of Radix Angelicae Sinensis, 20 grams of Cordyceps, 20 grams, Flos Carthami, 20 grams of Rhizoma Chuanxiongs, 20 grams, Semen Persicae, 20 grams of Herba Saussureae Involuerataes, 40 grams of Herba Leonuris, 50 grams of Radix Notoginseng, Oletum Trogopterori.In this case, the quantity of Radix Ginseng is less than Oletum Trogopterori.
200910019636.X relates to a kind of Chinese medicine composition for the treatment of palace blood and preparation method thereof, and it comprises Radix Ginseng, the Radix Astragali, Cortex Phellodendri, Carapax et Plastrum Testudinis, Radix Scutellariae, Fructus Rosae Laevigatae, the Radix Paeoniae Alba, Radix Polygoni Multiflori Preparata, Radix Glycyrrhizae Preparata, Radix Angelicae Sinensis, Rhizoma Cyperi, gun ginger, Radix Rehmanniae Preparata, Chinese mugwort charcoal, the Rhizoma Atractylodis Macrocephalae and cyrtomium rhizome charcoal.Radix Ginseng, the Radix Astragali, Radix Glycyrrhizae and Radix Angelicae Sinensis etc. are the good medicine for the treatment of qi depression to blood stasis.
201010263713.9 disclose a kind of medicine for the treatment of coronary heart disease and preparation method thereof, in this case people to participate in the proportioning of Oletum Trogopterori be 1 ~ 20:1 ~ 20.Oletum Trogopterori contains the composition that reduces Radix Ginseng effect, and people participates in Oletum Trogopterori at large ratio range compatibility, may reduce effect or have side effects.
201210537333.9 1 kinds of menorrheal Chinese medicine compositions for the treatment of, are made up of the each raw material of following weight portion: 20～40 parts of Radix Ginsengs, 20～40 parts of the Radixs Astragali, 10～20 parts of the Rhizoma Atractylodis Macrocephalaes, 3～9 parts of Radix Glycyrrhizae Preparatas, 3～9 parts of Rhizoma Cimicifugaes, 5～15 parts, Colla Corii Asini, 10～20 parts, the Radix Rehmanniae, 8～15 parts of Pollen Typhaes, 10～30 parts of Herba Leonuris, 5～15 parts of Oletum Trogopteroris, 3～9 parts of Radix Notoginseng, 3～9 parts, Radix Rubiae.In this Chinese medicinal components, Radix Ginseng is about two to four times of Oletum Trogopterori.
201010288583.4 disclose a kind of Chinese medicine preparation for the treatment of femur head necrosis, comprising: Radix Polygoni Multiflori Preparata 10-20 part, Radix Rehmanniae Preparata 10-20 part, Radix Angelicae Sinensis 10-15 part, Colla Corii Asini 10-15 part, Radix Paeoniae Alba 10-20 part, Radix Ginseng 5-10 part, Radix Codonopsis 10-20 part, Radix Pseudostellariae 10-20 part, Radix Astragali 10-20 part, Rhizoma Atractylodis Macrocephalae 10-20 part, Rhizoma Dioscoreae 10-20 part, Olibanum 10-15 part, Myrrha 10-15 part, Rhizoma Corydalis 10-15 part, Oletum Trogopterori 10-15 part.This case is treated femur head necrosis in the mode of blood circulation promoting and blood stasis dispelling, nourishing the liver and kidney.
201310468625.6 disclose a kind of formula of Radix Ginseng activating blood circulation to dissipate blood stasis wine, comprise Radix Ginseng 20-35 part, Rhizoma Corydalis 10-30 part, Concha Arcae 10-30 part, Radix Rubiae 10-30 part, Thallus Laminariae (Thallus Eckloniae) 10-30 part, Semen Raphani 10-30 part, wide art 10-30 part, Exocarpium Citri Rubrum 10-30 part, Oletum Trogopterori 10-30 part, Herba Lycopi 10-30 part, Rhizoma Sparganii 10-30 part, Lignum Sappan 10-30 part, Hirudo 10-30 part, Radix Achyranthis Bidentatae 10-30 part, Rhizoma Curcumae Longae 10-30 part, Caulis Hederae Sinensis 10-30 part, Flos Rosae Chinensis 10-30 part.In this case, the content of Radix Ginseng is slightly larger than Oletum Trogopterori.
The anginal Chinese medicine composition of this treatment qi stagnation and blood stasis type of the present invention, according to the mass fraction, consist of the following composition: 200 ~ 210 parts of Radix Salviae Miltiorrhizaes, 200 ~ 210 parts of the Radixs Astragali, 135 ~ 145 parts of Rhizoma Corydalis, 135 ~ 145 parts of Radix Ophiopogonis, 135 ~ 145 parts of Rhizoma Chuanxiongs, 135 ~ 140 parts of Radix Curcumaes, 125 ~ 130 parts, Pericarpium Citri Reticulatae Viride, 120 ~ 129 parts of Caulis Spatholobis, 120 ~ 129 parts of Fructus Crataegis, 120 ~ 129 parts of Fructus Trichosanthis, 120 ~ 125 parts of Radix Ginsengs, 105 ~ 110 parts, Semen Persicae, 105 ~ 110 parts of Stigma Crocis, 105 ~ 110 parts of Radix Paeoniae Rubra, 90 ~ 110 parts of Rhizoma Cyperis, 90 ~ 110 parts of Fructus Aurantiis, 86 ~ 110 parts of Pericarpium Citri Reticulataes, 86 ~ 89 parts, Radix Glycyrrhizae, 86 ~ 89 parts of Radix Angelicae Sinensis, 86 ~ 89 parts of Radix Bupleuri, 80 ~ 110 parts of Lignum Dalbergiae Odoriferaes, 80 ~ 110 parts of Fructus Amomis, 80 ~ 85 parts of Rhizoma Acori Graminei, 74 ~ 76 parts of Oletum Trogopteroris, 55 ~ 60 parts of Rhizoma Polygonati Odorati, 55 ~ 60 parts of Radix Notoginseng, 15 ~ 25 parts of Flos Jasmini Sambacs, 15 ~ 25 parts, Lignum Santali Albi, 8 ~ 10 parts of Borneolum Syntheticums.
Pharmacology: Radix Salviae Miltiorrhizae can blood circulation promoting and blood stasis dispelling, inducing menstruation to relieve menalgia.The Radix Astragali is longer than tonifying Qi and lifting yang, promote the production of body fluid and nourish blood, can with ginseng compatibility.Rhizoma Corydalis can be invigorated blood circulation, circulation of qi promoting, pain relieving.Radix Ophiopogonis can YIN nourishing and the production of body fluid promoting, and lung moistening clears away heart-fire.Rhizoma Chuanxiong can blood-activating and qi-promoting, wind-expelling pain-stopping.Radix Ginseng can strongly invigorating primordial QI.Fructus Trichosanthis energy promoting the circulation of QI dissipating depression of QI, is used for the treatment of coronary heart disease.Stigma Croci can removing blood stasis, promoting the circulation of blood and blood, tune blood, and strength is better than Flos Carthami.The pungent loose temperature of Pericarpium Citri Reticulatae Viride is logical, the capable and merit of long memorial liver and qi, removing obstruction for relieving pain of bitter diarrhea.Caulis Spatholobi returns liver, kidney channel, can blood circulation promoting and enriching, and menstruction regulating and pain relieving, Chang Peiwu benefiting QI for activating blood circulation dredging collateral medicine, as medicines such as the Radix Astragali, Radix Salviae Miltiorrhizae, Pheretimas.The Fructus Crataegi QI and blood of passing through, has the merit of promoting blood circulation to disperse blood clots and relieves pain, with Rhizoma Chuanxiong, Semen Persicae with using.Control the stagnant chest and hypochondrium of the stasis of blood, normal and Rhizoma Chuanxiong, Semen Persicae, Flos Carthami are equal to use.Radix Paeoniae Rubra is returned Liver Channel, can clearing away heat and cooling blood, and eliminating stasis to stop pain.Rhizoma Cyperi master enters Liver Channel edema caused by disorder of QI, fragrant pungent row, and the pent-up of kind loose irritability, bitter in the mouth catharsis is with the perverse and unreasonable manner of suppressing the hyperactive liver gas, thus be dispersing the stagnated live-QI to relieve the stagnation of QI, the key medicine of promoting the circulation of QI to relieve pain.Control the distending pain over the hypochondrium of depression of liver-QI, many and Radix Bupleuri, Rhizoma Chuanxiong, Fructus Aurantii are equal to use.Fructus Aurantii nature and flavor, return through, function and Fructus Aurantii Immaturus with, but effect relaxes, and is longer than circulation of qi promoting and opens breast, alleviating distention in middle-JIAO de-swelling.Radix Glycyrrhizae can coordinating the actions of various ingredients in a prescription, with the invigorating the spleen and replenishing QI such as Radix Ginseng, Radix Astragali medicine compatibility, for the card of deficiency-weakness of spleen-QI.Radix Angelicae Sinensis can be enriched blood and be invigorated blood circulation, menstruction regulating and pain relieving.Rhizoma Polygonati Odorati can nourishing YIN to relieve dryness, and promoting the production of body fluid to quench thirst, associated with Radix Ophiopogonis.Radix Curcumae can promoting blood circulation and stopping pain, promoting QI circulation for relieving depression, the removing heat from blood that clears away heart-fire, promoting the function of the gallbladder to alleviate jaundice.Semen Persicae can blood circulation promoting and blood stasis dispelling, loosening bowel to relieve constipation.The pungent row hardship of Radix Bupleuri is let out, and the kind bar of property reaches irritability, and dispersing the stagnated live-QI to relieve the stagnation of QI, can control and can control stagnation of QI due to depression of the liver.Lignum Dalbergiae Odoriferae can fall apart and can manage it, energy blood stasis dispelling regulating QI to relieve pain, and the available breast side of body trusted subordinate pain of controlling stagnation of QI and blood, is equal to use with Oletum Trogopterori, Rhizoma Chuanxiong, Radix Curcumae.Fructus Amomi can removing dampness circulation of qi promoting, controls the card of weakness of the spleen and stomach.Pericarpium Citri Reticulatae has Xin Hangwen logical, have promoting the circulation of QI to relieve pain, spleen invigorating and in merit.The pungent loose temperature of Lignum Santali Albi is logical and fragrant, has the merit in promoting the circulation of QI to relieve pain, cold expelling tune, often joins Fructus Amomi.Radix Notoginseng can dissipating blood stasis hemostasis, subduing swelling and relieving pain, the same use of compatibility blood-activating and qi-moving medicinal, the merit of the analgesic therapy of invigorating blood circulation is more outstanding.Oletum Trogopterori can promoting blood circulation and stopping pain, and removing stasis to stop bleeding, specially enters Liver Channel blood system, is good at promoting blood circulation, removing blood stasis and relieving pain, normal with Rhizoma Chuanxiong, Radix Salviae Miltiorrhizae with use.Rhizoma Acori Graminei GUIXIN warp, the beneficial will of can allaying excitement.Flos Jasmini Sambac can suppressing the hyperactive liver resolving depression, regulating QI to relieve pain.Borneolum Syntheticum GUIXIN, spleen, lung meridian, the refreshment of having one's ideas straightened out, clearing away heat to alleviate pain, unsuitable decoction.
Above pharmacology is observed herbal medicine efficacy and the combination principle of " Chinese Pharmacopoeia " (version in 2010) and " Chinese materia medica " (New Century higher institutions of Chinese medicine teaching material).But herbal pharmacology is profound, the summary of above pharmacology is not the whole pharmacology of the present invention.We are formed by multi-medicament compatibility, and combined effect, should not distinguish monarch.
embodiment mono-
One is treated the anginal Chinese medicine composition of qi stagnation and blood stasis type, consist of the following composition: Radix Salviae Miltiorrhizae 21.0g, Radix Astragali 20.8g, Rhizoma Corydalis 14g, Radix Ophiopogonis 14.5g, Rhizoma Chuanxiong 13.5g, Radix Curcumae 13.8g, Pericarpium Citri Reticulatae Viride 12.5g, Caulis Spatholobi 12.9g, Fructus Crataegi 12.4g, Fructus Trichosanthis 12.0g, Radix Ginseng 12.5g, Semen Persicae 10.5g, Stigma Croci 11g, Radix Paeoniae Rubra 10.5g, Rhizoma Cyperi 9.0g, Fructus Aurantii 11.0g, Pericarpium Citri Reticulatae 11.0g, Radix Glycyrrhizae 8.9g, Radix Angelicae Sinensis 8.6g, Radix Bupleuri 8.7g, Lignum Dalbergiae Odoriferae 11.0g, Fructus Amomi 8g, Rhizoma Acori Graminei 8.4g, Oletum Trogopterori 7.5g, Rhizoma Polygonati Odorati 6.0g, Radix Notoginseng 5.5g, Flos Jasmini Sambac 2.0g, Lignum Santali Albi 1.8g, Borneolum Syntheticum 0.8g.
One is used for the treatment of the anginal Chinese medicinal pill of qi stagnation and blood stasis type, comprises described Chinese medicine composition and Mel, and mass ratio is 1: ~ 1.5.
One is used for the treatment of the anginal Chinese medicine preparation of qi stagnation and blood stasis type, it is characterized in that comprising described Chinese medicine composition and solvent.In this Chinese medicine preparation, described solvent is rice wine, and by mass percentage, the proportioning of itself and Chinese medicine composition is 1:8.
embodiment bis-
One is treated the anginal Chinese medicine composition of qi stagnation and blood stasis type, consist of the following composition: Radix Salviae Miltiorrhizae 21.0g, Radix Astragali 21.0g, Rhizoma Corydalis 14.0g, Radix Ophiopogonis 14.5g, Rhizoma Chuanxiong 13.5g, Radix Curcumae 13.8g, Pericarpium Citri Reticulatae Viride 13.0g, Caulis Spatholobi 12.5g, Fructus Crataegi 12.4g, Fructus Trichosanthis 12.0g, Radix Ginseng 12.5g, Semen Persicae 10.5g, Stigma Croci 11.0g, Radix Paeoniae Rubra 10.5g, Rhizoma Cyperi 9.0g, Fructus Aurantii 11.0g, Pericarpium Citri Reticulatae 11.0g, Radix Glycyrrhizae 8.9g, Radix Angelicae Sinensis 8.7g, Radix Bupleuri 8.8g, Lignum Dalbergiae Odoriferae 11.0g, Fructus Amomi 8.0g, Rhizoma Acori Graminei 8.4g, Oletum Trogopterori 7.5g, Rhizoma Polygonati Odorati 6.0g, Radix Notoginseng 5.5g, Flos Jasmini Sambac 2.5g, Lignum Santali Albi 1.8g, Borneolum Syntheticum 0.8g.
One is used for the treatment of the anginal Chinese medicine preparation of qi stagnation and blood stasis type, it is characterized in that comprising described Chinese medicine composition and solvent.In this Chinese medicine preparation, described solvent is ethanol, and by mass percentage, the proportioning of itself and Chinese medicine composition is 1:3.
embodiment tri-
One is treated the anginal Chinese medicine composition of qi stagnation and blood stasis type, consist of the following composition: Radix Salviae Miltiorrhizae 20.5g, Radix Astragali 20.5g, Rhizoma Corydalis 14.0g, Radix Ophiopogonis 14.0g, Rhizoma Chuanxiong 14.0g, Radix Curcumae 13.5g, Pericarpium Citri Reticulatae Viride 12.8g, Caulis Spatholobi 12.5g, Fructus Crataegi 12.5g, Fructus Trichosanthis 12.5g, Radix Ginseng 12.4g, Semen Persicae 10.8g, Stigma Croci 10.8g, Radix Paeoniae Rubra 10.8g, Rhizoma Cyperi 10.0g, Fructus Aurantii 10.0g, Pericarpium Citri Reticulatae 9.5g, Radix Glycyrrhizae 8.8g, Radix Angelicae Sinensis 8.8g, Radix Bupleuri 8.8g, Lignum Dalbergiae Odoriferae 9.0g, Fructus Amomi 9.0g, Rhizoma Acori Graminei 8.5g, Oletum Trogopterori 7.46g, Rhizoma Polygonati Odorati 5.5g, Radix Notoginseng 5.5g, Flos Jasmini Sambac 1.5g, Lignum Santali Albi 2.0g, Borneolum Syntheticum 0.9g.
One is used for the treatment of the anginal Chinese medicine preparation of qi stagnation and blood stasis type, it is characterized in that comprising described Chinese medicine composition and solvent.In this Chinese medicine preparation, described solvent is ethanol, and by mass percentage, the proportioning of itself and Chinese medicine composition is 1:6.
embodiment tetra-
One is treated the anginal Chinese medicine composition of qi stagnation and blood stasis type, consist of the following composition: Radix Salviae Miltiorrhizae 20.0g, Radix Astragali 20.5g, Rhizoma Corydalis 14.5g, Radix Ophiopogonis 14.5g, Rhizoma Chuanxiong 14.5g, Radix Curcumae 13.7g, Pericarpium Citri Reticulatae Viride 12.6g, Caulis Spatholobi 12.0g, Fructus Crataegi 12.9g, Fructus Trichosanthis 12.5g, Radix Ginseng 12.0g, Semen Persicae 11.0g, Stigma Croci 10.5g, Radix Paeoniae Rubra 10.5g, Rhizoma Cyperi 9.0g, Fructus Aurantii 9.0g, Pericarpium Citri Reticulatae 8.6g, Radix Glycyrrhizae 8.9g, Radix Angelicae Sinensis 8.9g, Radix Bupleuri 8.6g, Lignum Dalbergiae Odoriferae 11.0g, Fructus Amomi 11.0g, Rhizoma Acori Graminei 8.4g, Oletum Trogopterori 7.4g, Rhizoma Polygonati Odorati 5.8g, Radix Notoginseng 5.8g, Flos Jasmini Sambac 2.0g, Lignum Santali Albi 2.2g, Borneolum Syntheticum 1.0g.
One is used for the treatment of the anginal Chinese medicine preparation of qi stagnation and blood stasis type, it is characterized in that comprising described Chinese medicine composition and solvent.In this Chinese medicine preparation, described solvent is ethanol, and by mass percentage, the proportioning of itself and Chinese medicine composition is 1:1.
embodiment five
One is treated the anginal Chinese medicine composition of qi stagnation and blood stasis type, consist of the following composition: Radix Salviae Miltiorrhizae 21.0g, Radix Astragali 20.0g, Rhizoma Corydalis 14.5g, Radix Ophiopogonis 14.5g, Rhizoma Chuanxiong 13.5g, Radix Curcumae 14.0g, Pericarpium Citri Reticulatae Viride 12.8g, Caulis Spatholobi 12.9g, Fructus Crataegi 12.0g, Fructus Trichosanthis 12.0g, Radix Ginseng 12.2g, Semen Persicae 10.5g, Stigma Croci 10.5g, Radix Paeoniae Rubra 11.0g, Rhizoma Cyperi 9.0g, Fructus Aurantii 11.0g, Pericarpium Citri Reticulatae 10.0g, Radix Glycyrrhizae 8.9g, Radix Angelicae Sinensis 8.9g, Radix Bupleuri 8.6g, Lignum Dalbergiae Odoriferae 8.5g, Fructus Amomi 8.5g, Rhizoma Acori Graminei 8.2g, Oletum Trogopterori 7.6g, Rhizoma Polygonati Odorati 6.0g, Radix Notoginseng 5.5g, Flos Jasmini Sambac 1.5g, Lignum Santali Albi 2.5g, Borneolum Syntheticum 0.8g.
One is used for the treatment of the anginal Chinese medicinal pill of qi stagnation and blood stasis type, it is characterized in that, comprises described Chinese medicine composition and Mel, and mass ratio is 1:1.
One is used for the treatment of the anginal Chinese medicine preparation of qi stagnation and blood stasis type, it is characterized in that comprising described Chinese medicine composition and solvent.In this Chinese medicine preparation, described solvent is yellow wine, and by mass percentage, the proportioning of itself and Chinese medicine composition is 1:10.
embodiment six
One is treated the anginal Chinese medicine composition of qi stagnation and blood stasis type, consist of the following composition: Radix Salviae Miltiorrhizae 20.5g, Radix Astragali 21.0g, Rhizoma Corydalis 13.5g, Radix Ophiopogonis 14.5g, Rhizoma Chuanxiong 13.5g, Radix Curcumae 13.5g, Pericarpium Citri Reticulatae Viride 12.5g, Caulis Spatholobi 12.0g, Fructus Crataegi 12.0g, Fructus Trichosanthis 12.9g, Radix Ginseng 12.5g, Semen Persicae 10.5g, Stigma Croci 10.5g, Radix Paeoniae Rubra 10.5g, Rhizoma Cyperi 9.0g, Fructus Aurantii 11.0g, Pericarpium Citri Reticulatae 8.6g, Radix Glycyrrhizae 8.9g, Radix Angelicae Sinensis 8.6g, Radix Bupleuri 8.6g, Lignum Dalbergiae Odoriferae 11.0g, Fructus Amomi 8.0g, Rhizoma Acori Graminei 8.0g, Oletum Trogopterori 7.6g, Rhizoma Polygonati Odorati 6.0g, Radix Notoginseng 5.5g, Flos Jasmini Sambac 2.0g, Lignum Santali Albi 1.5g, Borneolum Syntheticum 0.8g.
One is used for the treatment of the anginal Chinese medicinal pill of qi stagnation and blood stasis type, it is characterized in that, comprises described Chinese medicine composition and Mel, and mass ratio is 1:0.5.
One is used for the treatment of the anginal Chinese medicine preparation of qi stagnation and blood stasis type, it is characterized in that comprising described Chinese medicine composition and solvent.In this Chinese medicine preparation, described solvent is rice wine, and by mass percentage, the proportioning of itself and Chinese medicine composition is 1:10.
The consumption of each Chinese medicinal components of above embodiment does not represent potion consumption, in practical operation, generally divides two daily.The application does not limit the preparation method of this Chinese medicine composition, according to Chinese Pharmacopoeia, prepares, takes according to usual method.Certainly, according to experimental demonstration, Radix Ginseng and Oletum Trogopterori adopt aqueous solution or the drinks of concentration of alcohol more than 40%, and three hours at a simmer, edible with other component compatibilities, effect was better.
Typical case
1, Jiujiang tea ridge XXX, chest pain radiating to the back, uncomfortable in chest as stopped up.Checked and be diagnosed as angina pectoris by Ruichang the People's Hospital, differential diagnosis in tcm type is qi stagnation and blood stasis type, once cures at various big hospital, 5 years, has no obvious curative effects more.Within 2012, adopt we treatment, every day potion, every dose 100 to 150g, drink at twice.Chinese liquor decoction, Borneolum Syntheticum etc. are swallowed.After three months, take a turn for the better.
2, Duchang County, Jiangxi lion mountain area XXX, suffers from coronary heart disease and diabetes for a long time.Be diagnosed as angina pectoris, differential diagnosis in tcm type is qi stagnation and blood stasis type.Within 2011, adopt we treatment, every day, potion, every dose of 90g, drank at twice.Pill is swallowed.Take a turn for the better after two months.Visit 2 years without recurrence.
Each Chinese medicinal components of above embodiment can be used for the treatment of angina pectoris, especially effective to qi stagnation and blood stasis type angina pectoris, and it is to being about 92% take qi depression to blood stasis as the cure rate of main angina pectoris.Diabetes, metabolic arthritis for Coronary Artery Disease Complicated are also effective in cure, and cure rate is about 70%.
Claims (9)
1. the anginal Chinese medicine composition for the treatment of qi stagnation and blood stasis type, it is characterized in that, according to the mass fraction, consist of the following composition: 200 ~ 210 parts of Radix Salviae Miltiorrhizaes, 200 ~ 210 parts of the Radixs Astragali, 135 ~ 145 parts of Rhizoma Corydalis, 135 ~ 145 parts of Radix Ophiopogonis, 135 ~ 145 parts of Rhizoma Chuanxiongs, 135 ~ 140 parts of Radix Curcumaes, 125 ~ 130 parts, Pericarpium Citri Reticulatae Viride, 120 ~ 129 parts of Caulis Spatholobis, 120 ~ 129 parts of Fructus Crataegis, 120 ~ 129 parts of Fructus Trichosanthis, 120 ~ 125 parts of Radix Ginsengs, 105 ~ 110 parts, Semen Persicae, 105 ~ 110 parts of Stigma Crocis, 105 ~ 110 parts of Radix Paeoniae Rubra, 90 ~ 110 parts of Rhizoma Cyperis, 90 ~ 110 parts of Fructus Aurantiis, 86 ~ 110 parts of Pericarpium Citri Reticulataes, 86 ~ 89 parts, Radix Glycyrrhizae, 86 ~ 89 parts of Radix Angelicae Sinensis, 86 ~ 89 parts of Radix Bupleuri, 80 ~ 90 parts of Lignum Dalbergiae Odoriferaes, 80 ~ 90 parts of Fructus Amomis, 80 ~ 85 parts of Rhizoma Acori Graminei, 74 ~ 76 parts of Oletum Trogopteroris, 55 ~ 60 parts of Rhizoma Polygonati Odorati, 55 ~ 60 parts of Radix Notoginseng, 15 ~ 25 parts of Flos Jasmini Sambacs, 15 ~ 25 parts, Lignum Santali Albi, 8 ~ 10 parts of Borneolum Syntheticums.
2. Chinese medicine composition according to claim 1, it is characterized in that, consist of the following composition: 205 parts of Radix Salviae Miltiorrhizaes, 205 parts of the Radixs Astragali, 140 parts of Rhizoma Corydalis, 140 parts of Radix Ophiopogonis, 140 parts of Rhizoma Chuanxiongs, 135 parts of Radix Curcumaes, 125 parts, Pericarpium Citri Reticulatae Viride, 125 parts of Caulis Spatholobis, 125 parts of Fructus Crataegis, 125 parts of Fructus Trichosanthis, 124 parts of Radix Ginsengs, 108 parts, Semen Persicae, 108 parts of Stigma Crocis, 108 parts of Radix Paeoniae Rubra, 100 parts of Rhizoma Cyperis, 100 parts of Fructus Aurantiis, 95 parts of Pericarpium Citri Reticulataes, 88 parts, Radix Glycyrrhizae, 88 parts of Radix Angelicae Sinensis, 88 parts of Radix Bupleuri, 90 parts of Lignum Dalbergiae Odoriferaes, 90 parts of Fructus Amomis, 85 parts of Rhizoma Acori Graminei, 75 parts of Oletum Trogopteroris, 55 parts of Rhizoma Polygonati Odorati, 55 parts of Radix Notoginseng, 25 parts of Flos Jasmini Sambacs, 20 parts, Lignum Santali Albi, 9 parts of Borneolum Syntheticums.
3. Chinese medicine composition according to claim 1, it is characterized in that, consist of the following composition: 205 parts of Radix Salviae Miltiorrhizaes, 210 parts of the Radixs Astragali, 135 parts of Rhizoma Corydalis, 145 parts of Radix Ophiopogonis, 135 parts of Rhizoma Chuanxiongs, 135 parts of Radix Curcumaes, 130 parts, Pericarpium Citri Reticulatae Viride, 120 parts of Caulis Spatholobis, 120 parts of Fructus Crataegis, 129 parts of Fructus Trichosanthis, 125 parts of Radix Ginsengs, 105 parts, Semen Persicae, 105 parts of Stigma Crocis, 105 parts of Radix Paeoniae Rubra, 90 parts of Rhizoma Cyperis, 110 parts of Fructus Aurantiis, 86 parts of Pericarpium Citri Reticulataes, 89 parts, Radix Glycyrrhizae, 86 parts of Radix Angelicae Sinensis, 86 parts of Radix Bupleuri, 110 parts of Lignum Dalbergiae Odoriferaes, 80 parts of Fructus Amomis, 80 parts of Rhizoma Acori Graminei, 76 parts of Oletum Trogopteroris, 60 parts of Rhizoma Polygonati Odorati, 55 parts of Radix Notoginseng, 20 parts of Flos Jasmini Sambacs, 15 parts, Lignum Santali Albi, 8 parts of Borneolum Syntheticums.
4. Chinese medicine composition according to claim 1, it is characterized in that, consist of the following composition: 210 parts of Radix Salviae Miltiorrhizaes, 200 parts of the Radixs Astragali, 145 parts of Rhizoma Corydalis, 145 parts of Radix Ophiopogonis, 135 parts of Rhizoma Chuanxiongs, 140 parts of Radix Curcumaes, 126 parts, Pericarpium Citri Reticulatae Viride, 129 parts of Caulis Spatholobis, 120 parts of Fructus Crataegis, 120 parts of Fructus Trichosanthis, 122 parts of Radix Ginsengs, 105 parts, Semen Persicae, 105 parts of Stigma Crocis, 110 parts of Radix Paeoniae Rubra, 90 parts of Rhizoma Cyperis, 110 parts of Fructus Aurantiis, 100 parts of Pericarpium Citri Reticulataes, 89 parts, Radix Glycyrrhizae, 89 parts of Radix Angelicae Sinensis, 86 parts of Radix Bupleuri, 85 parts of Lignum Dalbergiae Odoriferaes, 85 parts of Fructus Amomis, 82 parts of Rhizoma Acori Graminei, 74.6 parts of Oletum Trogopteroris, 60 parts of Rhizoma Polygonati Odorati, 55 parts of Radix Notoginseng, 15 parts of Flos Jasmini Sambacs, 25 parts, Lignum Santali Albi, 8 parts of Borneolum Syntheticums.
5. Chinese medicine composition according to claim 1, it is characterized in that, consist of the following composition: 200 parts of Radix Salviae Miltiorrhizaes, 205 parts of the Radixs Astragali, 145 parts of Rhizoma Corydalis, 145 parts of Radix Ophiopogonis, 145 parts of Rhizoma Chuanxiongs, 137 parts of Radix Curcumaes, 128 parts, Pericarpium Citri Reticulatae Viride, 120 parts of Caulis Spatholobis, 129 parts of Fructus Crataegis, 125 parts of Fructus Trichosanthis, 120 parts of Radix Ginsengs, 110 parts, Semen Persicae, 105 parts, (Tibetan) Flos Carthami, 105 parts of Radix Paeoniae Rubra, 90 parts of Rhizoma Cyperis, 90 parts of Fructus Aurantiis, 86 parts of Pericarpium Citri Reticulataes, 89 parts, Radix Glycyrrhizae, 89 parts of Radix Angelicae Sinensis, 86 parts of Radix Bupleuri, 110 parts of Lignum Dalbergiae Odoriferaes, 110 parts of Fructus Amomis, 84 parts of Rhizoma Acori Graminei, 74 parts of Oletum Trogopteroris, 58 parts of Rhizoma Polygonati Odorati, 58 parts of Radix Notoginseng, 15 parts of Flos Jasmini Sambacs, 22 parts, Lignum Santali Albi, 20 parts of Borneolum Syntheticums.
6. be used for the treatment of the anginal Chinese medicinal capsule of qi stagnation and blood stasis type, it is characterized in that, comprise Chinese medicine composition as described in claim 1 to 5 any one.
7. be used for the treatment of the anginal Chinese medicinal pill of qi stagnation and blood stasis type, it is characterized in that, comprise Chinese medicine composition and Mel as described in claim 1 to 5 any one, mass ratio is 1:0.5 ~ 1.5.
8. be used for the treatment of the anginal Chinese medicine preparation of qi stagnation and blood stasis type, it is characterized in that comprising Chinese medicine composition and solvent as described in claim 1 to 5 any one, wherein, described solvent is rice wine, yellow wine or ethanol.
9. be used for the treatment of the anginal Chinese medicine preparation of qi stagnation and blood stasis type, it is characterized in that comprising Chinese medicine composition and solvent as described in claim 1 to 5 any one, wherein, in described solvent, contain mass fraction and be 40% to 90% ethanol.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410059638.2A CN103768537B (en) | 2014-02-23 | 2014-02-23 | Traditional Chinese medicine composition for treating qi-stagnation and blood stasis type angina pectoris |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410059638.2A CN103768537B (en) | 2014-02-23 | 2014-02-23 | Traditional Chinese medicine composition for treating qi-stagnation and blood stasis type angina pectoris |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103768537A true CN103768537A (en) | 2014-05-07 |
| CN103768537B CN103768537B (en) | 2017-02-08 |
Family
ID=50561597
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410059638.2A Expired - Fee Related CN103768537B (en) | 2014-02-23 | 2014-02-23 | Traditional Chinese medicine composition for treating qi-stagnation and blood stasis type angina pectoris |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103768537B (en) |
Cited By (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103948897A (en) * | 2014-05-13 | 2014-07-30 | 陈文才 | Traditional Chinese medicine for treating apoplexy sequel and application method thereof |
| CN104306584A (en) * | 2014-11-04 | 2015-01-28 | 王慧 | Preparation for treating rheumatic heart disease and oliguria and edema as well as preparation method thereof |
| CN104306565A (en) * | 2014-11-04 | 2015-01-28 | 王慧 | Traditional Chinese medicine preparation for treating qi stagnation and blood stasis type angina pectoris and preparation method thereof |
| CN105362493A (en) * | 2014-08-26 | 2016-03-02 | 熊家木 | Formulation special for tongue vein detoxification |
| CN105998629A (en) * | 2016-07-14 | 2016-10-12 | 成都嘉宝祥生物科技有限公司 | Traditional Chinese medicine composition for treating syndrome of qi stagnation and blood stasis |
| CN106075345A (en) * | 2016-07-14 | 2016-11-09 | 王全利 | A kind of compositions for treating angina pectoris and preparation thereof and preparation method |
| CN107669977A (en) * | 2017-08-25 | 2018-02-09 | 刘志聪 | A kind of medicinal liquor of promoting qi circulation and relieving pain |
| CN108744260A (en) * | 2018-06-27 | 2018-11-06 | 南阳市中心医院 | A kind of Cardiological medicated physical treatment device |
| CN110016397A (en) * | 2019-05-14 | 2019-07-16 | 孙建德 | The preparation method of the not bright heart-nourishing liquor of one seed sand |
| CN110384167A (en) * | 2018-04-19 | 2019-10-29 | 西藏新力成医药科技有限公司 | A kind of pressed candy and application thereof improving blood stasis constitution |
| CN115252691A (en) * | 2022-08-05 | 2022-11-01 | 长春中医药大学 | Traditional Chinese medicine composition for treating qi stagnation and blood stasis type coronary heart disease angina |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1136444A (en) * | 1995-05-22 | 1996-11-27 | 王希亚 | Medicine for curing coronary heart disease |
| CN1334121A (en) * | 2001-08-31 | 2002-02-06 | 石家庄以岭药业有限公司 | Medicinal composition for restoring cardiac collaterals and its application |
-
2014
- 2014-02-23 CN CN201410059638.2A patent/CN103768537B/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1136444A (en) * | 1995-05-22 | 1996-11-27 | 王希亚 | Medicine for curing coronary heart disease |
| CN1334121A (en) * | 2001-08-31 | 2002-02-06 | 石家庄以岭药业有限公司 | Medicinal composition for restoring cardiac collaterals and its application |
Cited By (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103948897A (en) * | 2014-05-13 | 2014-07-30 | 陈文才 | Traditional Chinese medicine for treating apoplexy sequel and application method thereof |
| CN105362493A (en) * | 2014-08-26 | 2016-03-02 | 熊家木 | Formulation special for tongue vein detoxification |
| CN104306584A (en) * | 2014-11-04 | 2015-01-28 | 王慧 | Preparation for treating rheumatic heart disease and oliguria and edema as well as preparation method thereof |
| CN104306565A (en) * | 2014-11-04 | 2015-01-28 | 王慧 | Traditional Chinese medicine preparation for treating qi stagnation and blood stasis type angina pectoris and preparation method thereof |
| CN105998629A (en) * | 2016-07-14 | 2016-10-12 | 成都嘉宝祥生物科技有限公司 | Traditional Chinese medicine composition for treating syndrome of qi stagnation and blood stasis |
| CN106075345A (en) * | 2016-07-14 | 2016-11-09 | 王全利 | A kind of compositions for treating angina pectoris and preparation thereof and preparation method |
| CN107669977A (en) * | 2017-08-25 | 2018-02-09 | 刘志聪 | A kind of medicinal liquor of promoting qi circulation and relieving pain |
| CN110384167A (en) * | 2018-04-19 | 2019-10-29 | 西藏新力成医药科技有限公司 | A kind of pressed candy and application thereof improving blood stasis constitution |
| CN108744260A (en) * | 2018-06-27 | 2018-11-06 | 南阳市中心医院 | A kind of Cardiological medicated physical treatment device |
| CN108744260B (en) * | 2018-06-27 | 2020-10-02 | 南阳市中心医院 | Intracardiac branch of academic or vocational study medicine physiotherapy device |
| CN110016397A (en) * | 2019-05-14 | 2019-07-16 | 孙建德 | The preparation method of the not bright heart-nourishing liquor of one seed sand |
| CN115252691A (en) * | 2022-08-05 | 2022-11-01 | 长春中医药大学 | Traditional Chinese medicine composition for treating qi stagnation and blood stasis type coronary heart disease angina |
| CN115252691B (en) * | 2022-08-05 | 2023-05-05 | 长春中医药大学 | Traditional Chinese medicine composition for treating qi stagnation and blood stasis type coronary heart disease angina |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103768537B (en) | 2017-02-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103768537B (en) | Traditional Chinese medicine composition for treating qi-stagnation and blood stasis type angina pectoris | |
| CN103784820B (en) | For treating Chinese medicine formula and the Chinese medicinal capsule of cardiovascular stasis coronary heart disease | |
| CN1124153C (en) | Medicinal composition for restoring cardiac collaterals and its application | |
| CN103341004B (en) | Chinese medicine composition for treating delayed menstrual cycle | |
| CN1951481A (en) | Medicament for treating cerebral thrombosis | |
| CN101095845A (en) | Century health preserving magical wine | |
| CN103860699B (en) | A kind of pharmaceutical composition for effecting a radical cure three-hypers | |
| CN103784888A (en) | Traditional Chinese medicine for treating coronary atherosclerotic heart disease caused by qi deficiency and blood stasis | |
| CN106668814A (en) | Traditional Chinese medicine formula for treating stroke | |
| CN108478731A (en) | Chinese medicine preparation and Chinese medicinal capsule for treating cardiovascular stasis coronary heart disease | |
| CN103301426A (en) | Capsule for invigorating circulation and benefiting heart | |
| CN102512632B (en) | Chinese herbal composition for treating abnormal menstruation | |
| CN104258297A (en) | Traditional Chinese medicine for treating qi stagnation and blood stasis type viral myocarditis and preparation method of traditional Chinese medicine | |
| CN104082745B (en) | For the conditioning of blood stasis body constitution and the medicated diet and the preparation method that improve immunoregulation capability | |
| CN103720996A (en) | Traditional Chinese medicinal composition for treating dysmenorrhea | |
| CN101773655A (en) | Anti-AIDS nanometer Chinese medicine and production method thereof | |
| CN104258292A (en) | Drug for department of obstetrics and gynecology for treating pregnancy complication and manufacturing method thereof | |
| CN1103223C (en) | Chinese medicine for treating cholecystitis | |
| CN105996024A (en) | Nourishing nutrient combination for soup cooking and preparation method of combination | |
| CN103356968B (en) | Traditional Chinese medicine composition for treating endometriosis | |
| CN104524159A (en) | Pharmaceutical composition for treating hyperplasia of mammary glands | |
| CN104435686A (en) | Use of traditional Chinese medicine preparation in preparation of medicine for treating skin itch and eczema papulosum | |
| CN103989907A (en) | Traditional Chinese medicine composition for treating amyloidosis cutis | |
| CN103211980A (en) | Traditional Chinese medicine composition for treatment of yin deficiency and yang excess | |
| CN101757206A (en) | Chinese medicine preparation for treating chronic colitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C41 | Transfer of patent application or patent right or utility model | ||
| CB03 | Change of inventor or designer information |
Inventor after: Fan Guangci Inventor after: Zhao Ying Inventor before: Cao Xiaosong |
|
| COR | Change of bibliographic data | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20160929 Address after: Two Zhangzhou Road, Shinan District 266000 Shandong city of Qingdao province No. 19 Applicant after: Fan Guangci Address before: 332600 Cao Baisi, floating village, Dagang Town, Duchang County, Jiangxi, Jiujiang Applicant before: Cao Xiaosong |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20170208 Termination date: 20180223 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |